• 1
    Hoigné R, Schluinberger HU, Vervloet D, Zoppi M. Epidemiology of allergic reactions. In: BurrM. editor. Epidemiology of clinical allergy. Epidemiology of allergic reactions to drugs. Monographs in Allergy, vol. 31. Basel : Karger, 1993:14070.
  • 2
    Bayard PJ, Berger TG, Jacobson MA. Drug hypersensitivity reactions and human immunodeficiency virus disease. J Acquir Immune Defic Syndr 1992;5:123757.
  • 3
    Geyman JP, Erickson S. The ampicillin rash as a diagnostic and management problem: case report and literature review. J Fam Pract 1978;7:4936.
  • 4
    Blanca M, Vega JM, Garcia J, Miranda A, Carmona MJ, Juarez C. New aspects of allergic reactions to betalactams: crossreactions and unique specificities. Clin Exp Allergv 1994;24:40715.
  • 5
    GellPG, CoombsRR, editors. The classification of allergic reactions underlying disease. In; Clinical aspects of immunology. Oxford : Blackwell Scientific. 1963.
  • 6
    Katz DH, Benacerraf B. The regulatory influence of activated T cells and B cell responses to antigen. Adv Immunol 1972;15:194.
  • 7
    Eisen HN, Orris L, Belman S. Elicitation of delayed allergic skin reactions to haptens: the dependence of elicitation on hapten combination with proteins. J Exp Med 1952;95:47381.
  • 8
    Carr A, Swanson C, Penny R, Cooper DA. Clinical and laboratory markers of hypersensitivity to trimethoprimsulfamethoxazole in patients with Pneumocystis carinii pneumonia and AIDS. J Infect Dis 1993;167:1805.
  • 9
    Porcelli SA, Morita CT, Modlin RL. T-cell recognition of non-peptide antigens. Curr Opin Immunol 1996;8:51016.
  • 10
    Morita CT, Beckman EM, Bukowski JF. et al. Direct presentation of nonpeptide prenyl pyrophosphate antigens to human γδ T cells. Immunity 1995;3:495507.
  • 11
    Beckman EM, Porcelli SA, Morita CT, Behar SM, Furlong ST, Brenner MB. Recognition of a lipid antigen by CD1-restricted αβ+ T cells. Nature 1994;372:6914.
  • 12
    Tanaka Y, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR. Nature and synthetic non-peptide antigens recognized by human γδ T cells. Nature 1995;375:1558.
  • 13
    Martin S, Weltzien HU. T cell recognition of haptens: a molecular view. Int Arch Allergy Immunol 1994;104:1016.
  • 14
    Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. T cell immune response to haptens: structural models for allergic and autoimmune reactions. Toxicology 1996;107:14151.
  • 15
    Ortmann B, Martin S, von Bohin A, Schlitz E, Hoschutzky H, Weltzien HU. Synthetic peptides anchor T-cell specific TNP epitopes to MHC antigens. J Immunol 1992;148:144550.
  • 16
    Köhler J, Hartmann U, Grimm R, Pflugfelder U, Weltzien HU. Carrier-independent hapten recognition and promiscuous MHC restriction by CD4+ T cells induced by trinitrophenylated peptides. J Immunol 1997;158:5917.
  • 17
    Batchelor FR, Janet MD, Gazzard DK. Penicillin allergy: the formation of the penicilloyl determinant. Nature 1965;206:3624.
  • 18
    Sullivan TJ. Drug allergy. In: MiddletonE, ReedCE, EllisEE, AdkinsonNF, YungingerJW, BusseWW, editors. Allergy: principles and practice. St Louis , MO : Mosby Year Book, 1993:172646.
  • 19
    Levine BB. Immunochemical mechanisms involved in penicillin hypersensitivity in experimental animals and in human beings. Fed Proc 1965;24:4550.
  • 20
    Parker CW. Immunochemical mechanisms in penicillin allergy. Fed Proc 1965;24:516.
  • 21
    de Weck AL, Schneider CW, Gutersohn J. The role of penicilloylated protein impurities, penicillin polymers and dimers in penicillin allergy. Int Arch Allergy Appl Immunol 1968;33:53542.
  • 22
    Park BK, Coleman JW, Kitteringham NR. Drug disposition and drug hypersensitivity. Biochem Pharmacol 1987;36:58160.
  • 23
    Levine BB, Redmond AP. Minor haptenic determinant-specific reagents of penicillin hypersensitivity in man. Int Arch Allergy Appl Immunol 1969;35:4459.
  • 24
    Koponen M, Pichler WJ, de Weck AL. T cell reactivity to penicillin: phenotypic analysis of in vitro activated cell subsets. J Allergy Clin Immunol 1986;78:64552.
  • 25
    Brander C, Mauri-Hellweg D, Bettens F, Rolli H, Goldman M, Pichler WJ. Heterogeneous T cell responses to β-lactam-modified self structures are observed in penicillin allergic individuals. J Immunol 1995;155:26708.
  • 26
    Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol 1996;26:428.
  • 27
    Mauri-Hellweg D, Zanni MP., Frei E, et al. Cross-reactivity Of T cell lines and clones to β-lactam antibiotics. J Immunol 1996;157:10719.
  • 28
    Padovan E, Bauer T, Tongio MM, Kalbacher H, Weltzien HU. Penicilloyl peptides are recognized as T cell antigenic determinants in penicillin allergy. Eur J Immunol 1997;27:13037.
  • 29
    Cribb AE, Spielberg SS. Sulfamethoxazole is metabolized to the hydroxylamine in humans. Clin Pharmacol Ther 1993;51:5226.
  • 30
    Leeder JS, Dosch HM, Spielberg SS. Cellular toxicity of sulfamethoxazole reactive metabolites. Biochem Pharmacol 1990;41:56773.
  • 31
    Grant DM, Morike K, Eichelbaum M, Meyer UA. Acetylation pharmacokinetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. J Clin Invest 1990;85:96872.
  • 32
    Rieder MJ, Shear NH, Kanee A, Tang BK, Spielberg SP. Prominence of slow acetylator phenotype among patients with sulfonamide hypersensitivity reactions. Clin Pharmacol Ther 1991;49:1317.
  • 33
    Cribb AE, Nakamura H, Grant DM, Miller MA, Spielberg SP. Role of polymorphic and monomorphic human arylamine N-acetyltransferase in determining sulfamethoxazole metabolism. Biochem Pharmacol 1993;45:127788.
  • 34
    Crispe IN, Mehal WZ. Strange brew: T cells in the liver. Immunol Today 1996;17:5225.
  • 35
    Huang Lin, Soldevila G, Leeker M, Flavell R, Crispe IN. The liver eliminates T cells undergoing antigen-triggered apoptosis in vivo. Immunity 1994;1:7419.
  • 36
    Schnyder B, Mauri-Hellweg D, Zanni MP, Bettens F, Pichler WJ. Direct, MHC dependent presentation of the drug sulfamethoxazole to human αβ T cell clones. J Clin Invest 1997;100:13640.
  • 37
    Zanni MP, von Greyerz S, Schnyder B, Vallitutti S, Pichler WJ. Rapid, HLA restricted, processing and metabolism independent recognition of drugs by human αβ+ lymphocytes. J Immunol (submitted).
  • 38
    Rhodes J, Chen H, Hall SR, et al. Therapeutic potentiation of the immune system by costimulatory Schiff-base-forming drugs. Nature 1995;376:1617.
  • 39
    Achari A, Somers DO, Chapness JN, Bryant PK, Rosemund J, Stammers DK. Crystal structure of the antibacterial sulfonamide drug target dihydropteroate synthase. Nature Struc Biol 1997;4:4907.
  • 40
    Romagnoli P, Spinas G A, Sinigaglia F. Gold-specific T cells in rheumatoid arthritis patients treated with gold. J Clin Invest 1992;89:2548.
  • 41
    Romagnoli PA, Labhardt M, Sinigaglia F. Selective interaction of Ni with an MHC-bound peptide. EMBO J 1991;10:13036.
  • 42
    Riley RJ, Leeder JS. In vitro analysis of metabolic predisposition to drug hypersensitivity reactions. Clin Exp Immunol 1995;99:16.
  • 43
    Jiang X, Khursigara G, Rubin RL. Transformation of lupusinducing drugs to cytotoxic products by activated neutrophils. Science 1995;266:81013.
  • 44
    Vittorio CC, Muglia JJ. Anticonvulsant hypersensitivity syndrome. Arch Intern Med 1995;155:22859.
  • 45
    De Vriese AS, Philippe J, van Renterghem DM, et al. Carbamazepine hypersensitivity syndrome: report of 4 cases and review of the literature. Medicine (Baltimore) 1995;74:14451.
  • 46
    van der Ven AJ, Koopmans PP, Vree TB, et al. Adverse reactions to co-trimoxazole in HIV infections. Lancet 1991;338:4313.
  • 47
    Pichler WJ. Medikamentenallergie. In: PeterHH, PichlerWJ. editors. Klinische Immunologie. Munchen : Urban & Schwarzenberg, 1996:71835.
  • 48
    Schnyder B, Frlitig K, Mauri-Hellweg D, et al. T cell mediated cytotoxicity in sulfamethoxazole induced skin reactions. J Clin Invest (submitted).
  • 49
    Mauri-Hellweg, D, Bettens F, Mauri D, Brander C, Hunziker T, Pichler WJ. Activation of drug-specific CD4+ and CD8+ T cells in individuals allergic to sulfamethoxazole, phenytoin and carbamazepine. J Immunol 1995;155:46272.
  • 50
    Zanni MP, Mauri-Hellweg D, Brander C, et al. Characterization of lidocaine specific T cells. J Immunol 1997;158:113948.
  • 51
    Hertl M, Jugert F, Merk HF. CD8+ dermal T cells from a sulfamethoxazole-induced bullous exanthem proliferate in response to drug-modified liver microsomes. Br J Dermatol 1995;132:21520.
  • 52
    Zanni MP, von Greyerz S, Schnyder B, Wendland T, Pichler WJ. Drug recognition by specific αβ+ T cell clones in association of multiple HLA-DR alleles. Immunol Int (submitted).
  • 53
    Pantaleo G, Demarest JF, Soudeyns H, et al. Major expansion of CD8+ T cells with a predominant Vβ usage during the primary immune response to HIV. Nature 1994;370:4637.
  • 54
    Pichler WJ, Mauri-Hellweg D, Baumann K, Bettens F. Selective expression of T cell receptor Vβ in acute infectious mononucleosis. Arch Int Med 1995;55:15556.
  • 55
    Moulon C, Vollmer J, Weltzien HU. Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol 1995;25:330815.
  • 56
    Vollmer J, Fritz M, Doromy A, Weltzien HU, Moulon C. Dominance of the BV17 element in nickel specific human T cell receptors relates to severity of contact sensitivity. Eur J Immunol 1997;27:186574.
  • 57
    Pichler WJ, Zanni M, von Greyerz S, Schnyder B, Mauri-Hellweg D, Wendland T. High IL-5 production by drug specific T cell clones. Int Arch Appl Allergy Immunol 1997;113:17780.
  • 58
    Dent LA, Strath M, Mellor AL, Anderson CJ. Eosinophilia in transgenic mice expressing interleukin 5. J Exp Med 1990;172:142531.
  • 59
    Merk HF, Hertl M. Immunologic mechanisms of cutaneous drug reactions. Semin Cutan Med Surg 1996;15:22835.
  • 60
    Hertl M, Bohlen H, Jugert F, Merk HF. Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by P-lactam antibiotics. J Invest Dermatol 1993;101:7949.
  • 61
    Herman A, Labrecque N, Thibodeau J, Marrack P, Kappler JW, Sekaly RP. Identification of the staphylococcal enterotoxin A superantigen binding site in the β1 domain of the human histocompatibility antigen HLA-DR. Proc Natl Acad Sci U S A 1991;88:99548.
  • 62
    Kappler J, Kotzian B, Herron L, et al. Vβ-specific stimulation of human T cells by staphylococcal toxins. Science 1989;244:81113.
  • 63
    Miranda A, Blanca M, Vega JM, et al. Cross-reactivity between a penicillin and a cephalosporin with the same side chain. J Allergy Clin Immunol 1996;98:6717.
  • 64
    Zanni MP, von Greyerz S, Schnyder B, Hari Y, Frei E, Pichler WJ. T cell reactivity to local anesthetics: in vivo and in vitro crossreactivity and identification of a possible core structure for T cell recognition. J Clin Invest (submitted).